MOG and demyelinating disease: Recently, autoantibodies to myelin oligodendrocyte glycoprotein (MOG), a component of the central nervous system myelin, were identified in a subset of demyelinating diseases (Reindl et al., 2013; Reindl and Waters, 2019).